Subdissociative-dose ketamine (SDDK) is used to treat acute pain. This study was a randomized double-blind placebo-controlled trial that sought to determine if SDDK is effective in relieving acute exacerbations of chronic pain.
17 December, 2024
Subdissociative-dose ketamine (SDDK) is used to treat acute pain. This study was a randomized double-blind placebo-controlled trial that sought to determine if SDDK is effective in relieving acute exacerbations of chronic pain.